Troutman Sanders advised Hong Kong-listed Shandong Weigao Medical Polymer Company Limited, a PRC incorporated, joint-stock company and a major supplier of consumable medical products for hospitals, in connection with its disposal of 50% equity interest in JW Medical Systems Limited to Biosensors International Group, a Singapore-listed company, for approximately HK$3.96 billion.
This deal was completed with cash of HK$1.01 billion, biosensors shares of HK$0.94 billion and convertible notes of HK$2.01 billion. This disposal enables Shandong Weigao to benefit from the dual brands and channels of JW Medical Systems Limited and Biosensors International Group for an unparalleled competitive advantage and international reach.
Troutman Sanders’ legal team was led by partner Shirley Lau (Hong Kong).
“We congratulate our client, Weigao Medical Polymer Company Limited, on its successful completion of this significant transaction,” said Shirley Lau.
Related Posts:
- None Found